Method and implantable system for blood-glucose concentration monitoring using parallel methodologies
US9282895B2 · kind B2 · utility
12Cited by
63References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2013 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Apr 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/7285
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
In an implantable medical device for monitoring glucose concentration in the blood, a blood-glucose concentration analysis is performed using correlations of blood-glucose concentration with measures of metabolic oxygen consumption including oxymetric, and/or temperature. Analysis of electrocardiographic data is used in a parallel method to detect and/or confirm the onset and/or existence and/or extent of hypoglycemia and/or hyperglycemia. Blood-glucose concentration calculation is enhanced by using the combination of the oxygen metabolism analysis and electrocardiographic analysis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.